{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:22:31Z","timestamp":1790947351530,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jaad.2017.12.004","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T22:20:57Z","timestamp":1512771657000},"page":"445-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Merkel cell carcinoma: An update and review"],"prefix":"10.1016","volume":"78","author":[{"given":"Tiffany L.","family":"Tello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Coggshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue S.","family":"Yom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegrid S.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.12.004_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.22765","article-title":"Merkel cell carcinoma: critical review with guidelines for multidisciplinary management","volume":"110","author":"Bichakjian","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.12.004_bib2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaad.2010.02.056","article-title":"Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system","volume":"63","author":"Lemos","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jaad.2017.12.004_bib4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.humpath.2010.12.013","article-title":"Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population","volume":"42","author":"Paik","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaad.2017.12.004_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(02)07668-7","article-title":"Merkel cell carcinoma and HIV infection","volume":"359","author":"Engels","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2017.12.004_bib6","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/00007890-199912150-00015","article-title":"Merkel\u2019s cell carcinoma in organ recipients: report of 41 cases","volume":"68","author":"Penn","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2017.12.004_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2133.2000.03370.x","article-title":"Two cases of Merkel cell tumour arising in patients with chronic lymphocytic leukaemia","volume":"142","author":"Ziprin","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib8","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/cancers6031328","article-title":"Merkel cell carcinoma in immunosuppressed patients","volume":"6","author":"Ma","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.jaad.2017.12.004_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1539\/joh.47.188","article-title":"Merkel cell carcinoma in patients with long-term ingestion of arsenic","volume":"47","author":"Ho","year":"2005","journal-title":"J Occup Health"},{"key":"10.1016\/j.jaad.2017.12.004_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/000313481508100819","article-title":"dramatic increase in the incidence and mortality from Merkel cell carcinoma in the United States","volume":"81","author":"Fitzgerald","year":"2015","journal-title":"Am Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/120347540000400403","article-title":"Merkel cell carcinoma of the skin","volume":"4","author":"Tai","year":"2000","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib12","series-title":"NCCN clinical practice guidelines in oncology for Merkel cell carcinoma","author":"Bichakjian","year":"2016"},{"issue":"2 pt 1","key":"10.1016\/j.jaad.2017.12.004_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0190-9622(93)70159-Q","article-title":"Merkel cell carcinoma","volume":"29","author":"Ratner","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib14","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1842::AID-CNCR13>3.0.CO;2-P","article-title":"Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations","volume":"88","author":"Gollard","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.12.004_bib15","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archsurg.1991.01410360088014","article-title":"Merkel cell carcinoma: prognosis and management","volume":"126","author":"Yiengpruksawan","year":"1991","journal-title":"Arch Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1524-4725.1996.tb00317.x","article-title":"Merkel cell carcinoma","volume":"22","author":"O\u2019Connor","year":"1996","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib17","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1200\/JCO.2005.02.329","article-title":"Merkel cell carcinoma: prognosis and treatment of patients from a single institution","volume":"23","author":"Allen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1524-4725.1995.tb00269.x","article-title":"Merkel cell carcinoma. Diagnosis and treatment","volume":"21","author":"Haag","year":"1995","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1524-4725.1997.tb00752.x","article-title":"Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients","volume":"23","author":"O'Connor","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib20","first-page":"165","article-title":"Merkel cell carcinoma of the skin and mucosa: report of 12 cutaneous cases with 2 cases arising from the nasal mucosa","volume":"27","author":"Snow","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1067\/mjd.2002.125083","article-title":"Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation","volume":"47","author":"Boyer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/DSS.0000000000000801","article-title":"Mohs micrographic surgery for the treatment of Merkel cell carcinoma","volume":"42","author":"Kline","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib23","doi-asserted-by":"crossref","first-page":"850797","DOI":"10.1155\/2013\/850797","article-title":"A practical update of surgical management of Merkel cell carcinoma of the skin","volume":"2013","author":"Tai","year":"2013","journal-title":"ISRN Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijrobp.2012.11.026","article-title":"The impact of preradiation residual disease volume on time to locoregional failure in cutaneous Merkel cell carcinoma\u2014a TROG substudy","volume":"86","author":"Finnigan","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jaad.2010.07.043","article-title":"Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients","volume":"65","author":"Pape","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bjd.14240","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases","volume":"174","author":"Gunaratne","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib27","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","article-title":"Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system","volume":"23","author":"Harms","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2013.11.031","article-title":"Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma","volume":"70","author":"Iyer","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib29","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1002\/cncr.29452","article-title":"Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma: tumor depth in Merkel cell carcinoma","volume":"121","author":"Smith","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.12.004_bib30","first-page":"113","article-title":"A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma","volume":"28","author":"Mehrany","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s10434-001-0204-4","article-title":"Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases","volume":"8","author":"Medina-Franco","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib32","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/cncr.26626","article-title":"Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma: recurrence in Merkel cell carcinoma","volume":"118","author":"Fields","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.12.004_bib33","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.6004\/jnccn.2016.0134","article-title":"Merkel cell carcinoma: a population analysis on survival","volume":"14","author":"Sridharan","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jaad.2017.12.004_bib34","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2967\/jnumed.112.116814","article-title":"18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience","volume":"54","author":"Siva","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jaad.2017.12.004_bib35","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/dsu.12246","article-title":"18F-fluorodeoxyglucose positron emission tomography\u2013computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study","volume":"39","author":"Ibrahim","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.12.004_bib36","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0360-3016(94)00610-W","article-title":"Radiation sensitivity of Merkel cell carcinoma cell lines","volume":"32","author":"Leonard","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaad.2017.12.004_bib37","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1245\/s10434-014-3757-8","article-title":"Outcomes of Merkel cell carcinoma treated with radiotherapy without radical surgical excision","volume":"21","author":"Harrington","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijrobp.2009.08.011","article-title":"The role of radiotherapy alone in patients with Merkel cell carcinoma: reporting the Australian experience of 43 patients","volume":"78","author":"Veness","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib39","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/cncr.24919","article-title":"Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma","volume":"116","author":"Fang","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.12.004_bib40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2009.05.067","article-title":"Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin","volume":"77","author":"Foote","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaad.2017.12.004_bib41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archderm.142.6.685","article-title":"Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature","volume":"142","author":"Gupta","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1529-8019.2008.00245.x","article-title":"Merkel cell carcinoma","volume":"21","author":"Liao","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2017.12.004_bib43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.adro.2016.10.003","article-title":"Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck","volume":"1","author":"Takagishi","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jaad.2007.03.011","article-title":"Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy","volume":"57","author":"Garneski","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib45","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archderm.142.6.693","article-title":"Adjuvant local irradiation for Merkel cell carcinoma","volume":"142","author":"Lewis","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11864-016-0409-1","article-title":"Merkel cell carcinoma therapeutic update","volume":"17","author":"Cassler","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib47","doi-asserted-by":"crossref","first-page":"djw042","DOI":"10.1093\/jnci\/djw042","article-title":"Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: survival analyses of 6908 cases from the National Cancer Data Base","volume":"108","author":"Bhatia","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2017.12.004_bib48","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1200\/JCO.2006.07.9319","article-title":"Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin","volume":"25","author":"Mojica","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib49","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/annonc\/mdr318","article-title":"Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study","volume":"23","author":"Jouary","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2017.12.004_bib51","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2017.12.004_bib52","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/cam4.458","article-title":"Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma","volume":"4","author":"Iyer","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.jaad.2017.12.004_bib53","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/j.ijrobp.2016.06.387","article-title":"Short-course radiation therapy for Merkel cell carcinoma: relative effectiveness in a \u201cradiosensitive\u201d tumor","volume":"96","author":"Cimbak","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib54","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.jcjo.2015.10.003","article-title":"Radioactive seed implantation in treatment of an eyelid primary Merkel cell carcinoma","volume":"51","author":"Hao","year":"2016","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jaad.2017.12.004_bib55","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1200\/JCO.2010.29.0635","article-title":"Treatment of cutaneous metastases of Merkel cell carcinoma with surface-mold computer-optimized high-dose-rate brachytherapy","volume":"28","author":"Cotter","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/PPO.0b013e31829e3566","article-title":"Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy","volume":"19","author":"Garibyan","year":"2013","journal-title":"Cancer J"},{"key":"10.1016\/j.jaad.2017.12.004_bib57","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2000.18.12.2493","article-title":"Chemotherapy in neuroendocrine\/Merkel cell carcinoma of the skin: case series and review of 204 cases","volume":"18","author":"Tai","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib58","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2589::AID-CNCR15>3.0.CO;2-F","article-title":"Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma","volume":"85","author":"Voog","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.12.004_bib59","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","article-title":"Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma","volume":"5","author":"Iyer","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.jaad.2017.12.004_bib60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/07357909109044222","article-title":"Chemotherapy of metastatic Merkel cell cancer","volume":"9","author":"Crown","year":"1991","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jaad.2017.12.004_bib61","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/1097-0142(19910415)67:8<2207::AID-CNCR2820670834>3.0.CO;2-R","article-title":"Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma","volume":"67","author":"Dirix","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.12.004_bib62","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1200\/JCO.2003.03.154","article-title":"High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin\/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study\u2014TROG 96:07","volume":"21","author":"Poulsen","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib63","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0360-3016(01)01577-2","article-title":"Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin\/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study","volume":"51","author":"Poulsen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaad.2017.12.004_bib64","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijrobp.2005.04.042","article-title":"Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?","volume":"64","author":"Poulsen","year":"2006","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib65","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1158\/2326-6066.CIR-14-0005","article-title":"Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma","volume":"2","author":"Paulson","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaad.2017.12.004_bib66","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2017.12.004_bib67","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1200\/JCO.2011.38.0899","article-title":"Cancer immunotherapy comes of age","volume":"29","author":"Topalian","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib68","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.12.004_bib69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti\u2013PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.12.004_bib70","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.12.004_bib71","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1634\/theoncologist.2015-0498","article-title":"FDA approval summary: pembrolizumab for the treatment of patients with metastatic non-small cell lung cancer whose tumors express programmed death-ligand 1","volume":"21","author":"Sul","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.jaad.2017.12.004_bib72","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Powles","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2017.12.004_bib73","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2326-6066.CIR-13-0034","article-title":"PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus, and overall survival","volume":"1","author":"Lipson","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaad.2017.12.004_bib74","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.12.004_bib75","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2017.12.004_bib76","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1158\/1078-0432.CCR-13-0035","article-title":"Merkel polyomavirus-specific T cells Fluctuate with Merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers","volume":"19","author":"Afanasiev","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2017.12.004_bib77","doi-asserted-by":"crossref","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-H1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaad.2017.12.004_bib78","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib79","author":"Schadendorf"},{"key":"10.1016\/j.jaad.2017.12.004_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/2326-6066.CIR-13-0087","article-title":"Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of reinducing HLA class-I","volume":"2","author":"Chapuis","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaad.2017.12.004_bib81","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3747\/co.23.2878","article-title":"Immunotherapy with imiquimod and interferon alfa for metastasized Merkel cell carcinoma","volume":"23","author":"Wahl","year":"2016","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib82","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/ijc.29885","article-title":"Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects: perioperative treatment with the new synthetic TLR-4 agonist GLA-SE","volume":"138","author":"Matzner","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2017.12.004_bib83","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-11-2308","article-title":"Activation of PI3K signaling in Merkel cell carcinoma","volume":"18","author":"Nardi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2017.12.004_bib84","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/COC.0b013e3181b9cf04","article-title":"A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): a Southwest Oncology Group Study (S0331)","volume":"33","author":"Samlowski","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib85","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.humpath.2014.07.025","article-title":"Comparison of Akt\/mTOR\/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus\u2013positive and Merkel cell polyomavirus\u2013negative carcinomas","volume":"46","author":"Iwasaki","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaad.2017.12.004_bib86","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000381062","article-title":"Somatostatin receptors 2A and 5 are expressed in Merkel cell carcinoma with no association with disease severity","volume":"101","author":"Gardair","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jaad.2017.12.004_bib87","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/bjc.2016.377","article-title":"Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours","volume":"115","author":"Childs","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2017.12.004_bib88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02738814","article-title":"Quantitation of somatostatin receptor type 2 in neuroendocrine (Merkel cell) carcinoma of the skin by competitive RT-PCR","volume":"10","author":"Papotti","year":"1999","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.jaad.2017.12.004_bib89","first-page":"1359","article-title":"Merkel cell tumor. Report of case and treatment with octreotide","volume":"52","author":"Cirillo","year":"1997","journal-title":"Minerva Chir"},{"key":"10.1016\/j.jaad.2017.12.004_bib90","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4103\/0973-1482.73352","article-title":"Remission of Merkel cell tumor after somatostatin analog treatment","volume":"6","author":"Fakiha","year":"2010","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.jaad.2017.12.004_bib91","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/ERC-15-0002","article-title":"Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors","volume":"22","author":"Dasari","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jaad.2017.12.004_bib92","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/modpathol.2008.63","article-title":"Expression of VEGF-A\/C, VEGF-R2, PDGF-\u03b1\/\u03b2, c-kit, EGFR, Her-2\/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma","volume":"21","author":"Brunner","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2017.12.004_bib93","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1200\/JCO.2009.21.8149","article-title":"Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma","volume":"27","author":"Davids","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib94","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMc1507446","article-title":"Response to idelalisib in a patient with stage IV Merkel-cell carcinoma","volume":"373","author":"Shiver","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.12.004_bib95","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1245\/s10434-009-0615-1","article-title":"Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone","volume":"16","author":"Bajetta","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2017.12.004_bib96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2009.06.021","article-title":"The impact of 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia","volume":"62","author":"Concannon","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.12.004_bib97","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1158\/0008-5472.CAN-10-2128","article-title":"Antibodies to Merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients","volume":"70","author":"Paulson","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2017.12.004_bib98","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bjd.14313","article-title":"Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma","volume":"174","author":"Samimi","year":"2016","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217327585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217327585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:45:08Z","timestamp":1759272308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217327585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0190962217327585"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.12.004","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Merkel cell carcinoma: An update and review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}